<DOC>
	<DOCNO>NCT00852839</DOCNO>
	<brief_summary>This clinical study determine whether daily administration formulation 552-02 improves dry mouth condition subject primary Sjögren 's syndrome .</brief_summary>
	<brief_title>A Safety Efficacy Study 552-02 Subjects With Dry Mouth Associated With Sjogren 's Syndrome</brief_title>
	<detailed_description>The primary objective clinical study determine whether daily administration oromucosal formulation 552-02 improves global assessment dry mouth , assess visual analog scale ( VAS ) , subject primary Sjögren 's syndrome . The secondary objective study follow : - To evaluate safety daily administration oromucosal formulation 552-02 subject primary Sjögren 's syndrome . - To evaluate whether administration oromucosal formulation 552-02 improves subjective measurement 6 different salivary function , measure use VAS , subject primary Sjögren 's syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<criteria>Male female , age 18 80 year ( inclusive ) , capable provide write informed consent . Male subject must either sexually active , surgically sterilize , agree use appropriate `` doublebarrier '' method study participation least 30 day completion dose . Nonpregnant female subject must either sexually active , postmenopausal , surgically sterilize ; agree use appropriate `` doublebarrier '' method ; currently use prescribe transdermal , injection , implant , oral contraceptive least 30 day study participation least 30 day completion dosing . Good health , determine medical history , physical examination , detailed oral examination , 12lead ECG , measurement clinical chemistry , hematology , urinalysis , serology data . Demonstrated minimal level unstimulated whole mouth salivary flow ( great equal 0.05 milliliter [ ie , 0.05 gram ] per 5 minute ) . Demonstrated clinically significant , moderate severe level dry mouth screen determine his/her score 100mm global VAS dry mouth symptom anchor range 'not dry ' ( 0 ) 'dry desert ' ( 100 ) follow : Minimal VAS score 50 mm Visit 1 . Diagnosis primary Sjögren 's syndrome . Currently use potassiumsparing diuretic antihypertensive drug contains amiloride ; spironolactone ( e.g. , Aldactone , NovoSpiroton , Spiractin , Spirtone , Verospiron Berlactone ) ; triamterene ( e.g. , Dyrenium ) ; plerenone ( e.g. , Inspra ) . Chronic use antihistamine permit start least 30 day Visit 1 , stable dose maintain throughout trial . Started use systemic cholinergic secretagogues tricyclic antidepressant drug within 12 week screen , stable dose regimen least 14 day prior Screening visit , unable maintain stable dose throughout study . Unable withhold use oral comfort agent ( eg , Oasis , MouthKote , etc ) follow enrollment study ( Visit 1 ) . Shows evidence significant active ongoing oral infection oral condition ( eg , lichen planus ) , opinion Investigator , might affect safety subject exacerbate study participation . Acutely infected salivary gland suspected closure salivary gland . A condition may confound diagnosis primary Sjögren 's syndrome . Received investigational drug within past 30 day . Received 55202 previous study . History multiple drug allergy allergy medicine chemically related study drug ( eg , amiloride , Moduretic , Midamor , triamterene ) . Any clinically significant allergic disease , include food allergy , exception nonactive hayfever . Present history clinically significant uncontrolled neurologic , gastrointestinal , renal , hepatic , cardiovascular , psychological , pulmonary , metabolic , endocrine , hematological disorder disease , major disorder disease , opinion Investigator . Sitting blood pressure screen high 150/90 mmHg low 100/50 mmHg rest 5 minute . Sitting pulse rate screening outside range 50 90 beat per minute ( bpm ) rest 5 minute . Consumes 2 alcoholic drink per day significant history alcoholism drug/chemical abuse within past 12 month . History use tobacco product within last 3 month . Has viral hepatitis test positively hepatitis B surface antigen ( HBsAg ) hepatitis C ( nonA , nonB ) antibody , positive result human immunodeficiency virus ( HIV ) antibody . Positive serum pregnancy test nursing ( female subject ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Dry mouth</keyword>
	<keyword>Sjogren 's syndrome</keyword>
	<keyword>Xerostomia</keyword>
</DOC>